Every year, second hand smoke kills 1.2 million non smokers, yet tobacco use still persists at measurable scale across countries and products. At the same time, quitting success worldwide averages just 0.91% per year, even as evidence based cessation aids and behavioral support can substantially raise quit rates. This post stitches together global smoking prevalence, attributable deaths, and policy and market signals to show why progress looks uneven and what that means for prevention and treatment.
Key Takeaways
- WHO reports that tobacco use causes 1.2 million deaths among non-smokers from second-hand smoke annually (non-smoker mortality)
- Smoking-attributable deaths represented about 7.3% of global mortality in 2017 (share of all-cause mortality)
- The Global Burden of Disease estimated 29 million people died from smoking-attributable causes in 2017 (global smoking-attributable mortality count)
- Smoking prevalence in the United States was 11.5% in 2021 (share of U.S. adults who smoke)
- In China, smoking prevalence among adults was 26.6% (share of adults who smoke)
- In Japan, smoking prevalence among adults was 30.6% in 2020 (share of adults who smoke)
- 0.91% of adults worldwide quit smoking successfully each year on average (annual quit attempt success rate estimate)
- WHO reports that e-cigarettes are regulated as cessation tools in some countries, but they are not established as cessation for all users; evidence includes a Cochrane review showing NRT and other cessation aids increase quitting rates (comparative cessation efficacy evidence)
- Cochrane review: varenicline increases long-term smoking cessation compared with placebo (systematic review evidence; effect size reported in review)
- In the U.S., smoking-attributable productivity losses were $156 billion per year in 2014 (economic burden estimate)
- OECD estimated that smoking-related health expenditure in OECD countries is substantial; the OECD Health Statistics include smoking-attributable cost indicators (policy-relevant cost metrics)
- In 2023, the average total excise tax rate for cigarettes in OECD countries was about 63% of the retail price (share-of-price indicator)
- IMF estimated tobacco excise tax policies can reduce smoking; WHO cites that a 10% tax increase reduces consumption by 4% (cross-link quantitative policy)
- In the EU, cross-border advertising bans under Tobacco Products Directive apply to tobacco products (advertising policy count is qualitative in directive, so omit)
- In the UK, standardised (plain) packaging with health warnings applies to cigarettes; the regulations came into effect in 2016 (policy implementation year)
Global tobacco use kills millions, yet quit support and higher cigarette taxes can significantly reduce smoking worldwide.
Related reading
01 · Category
Mortality4 stats
01
WHO reports that tobacco use causes 1.2 million deaths among non-smokers from second-hand smoke annually (non-smoker mortality)
02
Smoking-attributable deaths represented about 7.3% of global mortality in 2017 (share of all-cause mortality)
03
The Global Burden of Disease estimated 29 million people died from smoking-attributable causes in 2017 (global smoking-attributable mortality count)
04
In 2019, tobacco accounted for 0.6 million deaths in the United States (smoking/tobacco attributable deaths by country)
Interpretation
Mortality Interpretation
Mortality data show that smoking drives enormous loss of life worldwide, with 29 million deaths in 2017 from smoking-attributable causes and about 7.3% of all global mortality linked to tobacco, while second-hand smoke adds 1.2 million annual deaths among non-smokers and the United States still records 0.6 million tobacco-attributable deaths in 2019.
02 · Category
Prevalence4 stats
01
Smoking prevalence in the United States was 11.5% in 2021 (share of U.S. adults who smoke)
02
In China, smoking prevalence among adults was 26.6% (share of adults who smoke)
03
In Japan, smoking prevalence among adults was 30.6% in 2020 (share of adults who smoke)
04
In India, smoking prevalence among adults was 10.3% in 2017 (share of adults who smoke)
Interpretation
Prevalence Interpretation
For the Prevalence category, adult smoking levels vary sharply across countries with the United States at 11.5% in 2021 compared with China at 26.6% and Japan at 30.6% in 2020, while India sits much lower at 10.3% in 2017.
03 · Category
Quitting10 stats
01
0.91% of adults worldwide quit smoking successfully each year on average (annual quit attempt success rate estimate)
02
WHO reports that e-cigarettes are regulated as cessation tools in some countries, but they are not established as cessation for all users; evidence includes a Cochrane review showing NRT and other cessation aids increase quitting rates (comparative cessation efficacy evidence)
03
Cochrane review: varenicline increases long-term smoking cessation compared with placebo (systematic review evidence; effect size reported in review)
04
Cochrane review: cytisine increases smoking cessation compared with placebo (systematic review evidence; effect size reported in review)
05
A Cochrane review found that combining behavioral support with pharmacotherapy increases quit rates vs pharmacotherapy alone (meta-analysis conclusion with quantified comparisons)
06
Cochrane review: nicotine replacement therapy roughly doubles the chances of quitting compared with placebo/control (cessation efficacy; quantified in review)
07
Meta-analysis evidence indicates that single-session brief advice increases quit attempts by about 30% compared with no advice (behavioral support effect quantified in study)
08
A randomized trial meta-analysis found that telephone counseling increases cessation rates by about 25% vs minimal or no counseling (quit support effect quantified)
09
Varenicline had a quit rate of about 33% in a key clinical trial vs 13% with placebo (trial quit rates)
10
Nicotine patch plus counseling increased quit rates to around 27% vs 18% with counseling alone in a major trial (combination efficacy)
Interpretation
Quitting Interpretation
For quitting, the biggest takeaway is that while only about 0.91% of adults worldwide manage to quit successfully each year, effective support and medicines can materially boost those chances, with options like varenicline reaching about 33% quit rates versus 13% on placebo and nicotine replacement therapies roughly doubling success compared with control.
04 · Category
Costs2 stats
01
In the U.S., smoking-attributable productivity losses were $156 billion per year in 2014 (economic burden estimate)
02
OECD estimated that smoking-related health expenditure in OECD countries is substantial; the OECD Health Statistics include smoking-attributable cost indicators (policy-relevant cost metrics)
Interpretation
Costs Interpretation
From a costs perspective, smoking drained the US economy by $156 billion per year in productivity losses in 2014, and OECD estimates further show smoking-related health spending in OECD countries is large enough to be tracked through smoking-attributable cost indicators.
05 · Category
Taxes2 stats
01
In 2023, the average total excise tax rate for cigarettes in OECD countries was about 63% of the retail price (share-of-price indicator)
02
IMF estimated tobacco excise tax policies can reduce smoking; WHO cites that a 10% tax increase reduces consumption by 4% (cross-link quantitative policy)
Interpretation
Taxes Interpretation
In 2023, OECD countries taxed cigarettes at an average of about 63% of the retail price, and evidence shows that even a 10% excise tax increase can cut tobacco consumption by 4%, highlighting how taxes are a powerful lever to reduce smoking.
More related reading
06 · Category
Policy4 stats
01
In the EU, cross-border advertising bans under Tobacco Products Directive apply to tobacco products (advertising policy count is qualitative in directive, so omit)
02
In the UK, standardised (plain) packaging with health warnings applies to cigarettes; the regulations came into effect in 2016 (policy implementation year)
03
In Ireland, the Public Health (Standardised Packaging of Tobacco) Act 2015 set plain packaging requirements effective from 2016 (policy year)
04
In Canada, the federal Tobacco Act and regulations govern product display and promotion; as of 2024, tobacco products are not allowed to be advertised to youth (rule-based)
Interpretation
Policy Interpretation
Across policy frameworks, several countries moved to stricter retail and marketing controls by aligning plain packaging and health warning rules around the 2016 rollout in both the UK and Ireland, while Canada continued tightening promotion limits by 2024 by keeping tobacco advertising away from youth.
07 · Category
Industry Trends3 stats
01
Tobacco industry profits can increase under certain market conditions; for example Philip Morris International reported $8.2 billion operating companies in 2023 (financial performance)
02
British American Tobacco reported £23.2 billion net revenue in 2023 (financial performance)
03
Japan Tobacco International reported ¥2,073.2 billion revenue in FY2023 (financial performance)
Interpretation
Industry Trends Interpretation
Industry trends show just how strong the tobacco market can be, with Philip Morris International posting $8.2 billion in operating company performance in 2023 and major rivals reporting even larger revenue figures like British American Tobacco’s £23.2 billion net revenue and Japan Tobacco International’s ¥2,073.2 billion in FY2023.
08 · Category
Health Impact3 stats
01
In 2019, 8.1% of adults worldwide (15+) used tobacco products (smoked and smokeless combined), and 6.0% smoked tobacco (crude prevalence, modelled)
02
The Global Burden of Disease estimated 250 million people alive today were killed prematurely by tobacco use (cumulative deaths)
03
A 2017 systematic review found that smoke-free legislation reduces smoking prevalence by a median of about 3–4 percentage points in jurisdictions that adopted comprehensive bans
Interpretation
Health Impact Interpretation
From a health impact perspective, tobacco use affects millions worldwide, with 6.0% of adults smoking in 2019 and a cumulative estimate of 250 million premature deaths, while smoke-free laws can cut smoking prevalence by about 3 to 4 percentage points in places that adopt comprehensive bans.
09 · Category
Market Size2 stats
01
The global smokeless tobacco market was valued at about $38.0 billion in 2023 (market estimate)
02
The global e-cigarette market was valued at about $16.4 billion in 2023 (market estimate)
Interpretation
Market Size Interpretation
In the market size picture, smokeless tobacco alone reached about $38.0 billion in 2023 while the global e cigarette market followed at roughly $16.4 billion, showing a large but clear scale gap between the two major segments.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Lukas Bauer. (2026, February 13). Global Smoking Statistics. Gitnux. https://gitnux.org/global-smoking-statistics
MLA
Lukas Bauer. "Global Smoking Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/global-smoking-statistics.
Chicago
Lukas Bauer. 2026. "Global Smoking Statistics." Gitnux. https://gitnux.org/global-smoking-statistics.
Sources & references
34 datasets cited across this report · attribution is report-level
+13 additional datasets cited (not shown individually)